New Oral Anticoagulants and the Cancer Patient

Por Short, Nicholas J., Connors, Jean M.
Publicado em 2014

Bunyamwera Virus Replication in Cultured Aedes albopictus (Mosquito) Cells: Establishment of a Persistent Viral Infection

Por Newton, Susan E., Short, Nicholas J., Dalgarno, Lynn
Publicado em 1981

The DNA-binding protein of Pf1 filamentous bacteriophage: amino-acid sequence and structure of the gene

Por Maeda, Kayo, Kneale, G. Geoff, Tsugita, Akira, Short, Nicholas J., Perham, R.N., Hill, Diana F., Petersen, George B.
Publicado em 1982

Quality and Cost Comparison of Powered Versus Manual Bone Marrow Biopsy Devices in Patients with Myelofibrosis

Por Maiti, Abhishek, Short, Nicholas J., Verstovsek, Srdan, Powers, Cynthia A., Fullmer, Cheryl A., Reyes, Steven R., Bueso-Ramos, Carlos E.
Publicado no Leuk Lymphoma (2017)

Fludarabine, Cyclophosphamide, and Multiple-Dose Rituximab as Frontline Therapy for Chronic Lymphocytic Leukemia

Por Short, Nicholas J., Keating, Michael J., Wierda, William G., Faderl, Stefan, Ferrajoli, Alessandra, Estrov, Zeev, Smith, Susan C., O'Brien, Susan M.
Publicado no Cancer (2015)

Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Por Short, Nicholas J., Jabbour, Elias, Sasaki, Koji, Patel, Keyur, O’Brien, Susan M., Cortes, Jorge E., Garris, Rebecca, Issa, Ghayas C., Garcia-Manero, Guillermo, Luthra, Rajyalakshmi, Thomas, Deborah, Kantarjian, Hagop, Ravandi, Farhad
Publicado no Blood (2016)

Hyper-CVAD + ponatinib vs. hyper-CVAD + dasatinib as frontline therapy for Ph-positive ALL: a propensity score analysis

Por Sasaki, Koji, Jabbour, Elias, Ravandi, Farhad, Short, Nicholas J., Thomas, Deborah, Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Issa, Ghayas C., Jeanis, Vicki, Moore, Gal, Garris, Rebecca, Pemmaraju, Naveen, Cortes, Jorge E., O'Brien, Susan, Kantarjian, Hagop
Publicado no Cancer (2016)

Peripheral blood blast clearance is an independent prognostic factor for survival and response to AML induction chemotherapy

Por Short, Nicholas J., Benton, Christopher B., Chen, Hsiang-Chun, Qiu, Peng, Gu, Lisa, Pierce, Sherry, Brandt, Mark, Maiti, Abhishek, Min, Taejin L., Naqvi, Kiran, Quintas-Cardama, Alfonso, Konopleva, Marina, Kadia, Tapan, Cortes, Jorge, Garcia-Manero, Guillermo, Ravandi, Farhad, Jabbour, Elias, Kantarjian, Hagop, Andreeff, Michael
Publicado no Am J Hematol (2016)

Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents

Por Jabbour, Elias, Strati, Paolo, Cabrero, Monica, O’Brien, Susan, Ravandi, Farhad, Bueso-Ramos, Carlos, Wei, Qiao, Hu, Jianhua, Aad, Simon Abi, Short, Nicholas J, Dinardo, Courtney, Daver, Naval, Kadia, Tapan, Wierda, William, Wei, Yue, Colla, Simona, Borthakur, Gautam, Cortes, Jorge, Estrov, Zeev, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado no Am J Hematol (2017)

Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative ALL

Por Short, Nicholas J., Kantarjian, Hagop, Sasaki, Koji, Cortes, Jorge E., Ravandi, Farhad, Thomas, Deborah, Garcia-Manero, Guillermo, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, Issa, Ghayas C., Konopleva, Marina, Kadia, Tapan M., Bueso-Ramos, Carlos, Khoury, Joseph D., Jain, Nitin, O’Brien, Susan M., Jabbour, Elias
Publicado no Cancer (2016)

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative ALL in the era of MRD

Por Issa, Ghayas C., Kantarjian, Hagop, Yin, C. Cameron, Qiao, Wei, Ravandi, Farhad, Thomas, Deborah, Short, Nicholas J., Sasaki, Koji, Garcia-Manero, Guillermo, Kadia, Tapan M., Cortes, Jorge E., Daver, Naval, Borthakur, Gautam, Jain, Nitin, Konopleva, Marina, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, O'Brien, Susan M., Jabbour, Elias
Publicado no Cancer (2016)

Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase...

Por Short, Nicholas J., Kantarjian, Hagop M., Sasaki, Koji, Ravandi, Farhad, Ko, Heidi, Yin, C. Cameron, Garcia-Manero, Guillermo, Cortes, Jorge E., Garris, Rebecca, O'Brien, Susan M., Patel, Keyur, Khouri, Maria, Thomas, Deborah, Jain, Nitin, Kadia, Tapan M., Daver, Naval, Benton, Christopher B., Issa, Ghayas C., Konopleva, Marina, Jabbour, Elias
Publicado no Am J Hematol (2017)

Differential impact of minimal residual disease negativity according to salvage status in patients with relapsed/refractory B cell acute lymphoblastic leukemia

Por Jabbour, Elias, Short, Nicholas J., Jorgensen, Jeffrey L., Yilmaz, Musa, Ravandi, Farhad, Wang, Sa A., Thomas, Deborah A., Khoury, Joseph, Champlin, Richard E., Khouri, Issa, Kebriaei, Partow, O’Brien, Susan M., Garcia-Manero, Guillermo, Cortes, Jorge E., Sasaki, Koji, Dinardo, Courtney D., Kadia, Tapan M., Jain, Nitin, Konopleva, Marina, Garris, Rebecca, Kantarjian, Hagop
Publicado no Cancer (2016)

Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN

Por Jabbour, Elias, Short, Nicholas J., Montalban-Bravo, Guillermo, Huang, Xuelin, Bueso-Ramos, Carlos, Qiao, Wei, Yang, Hui, Zhao, Chong, Kadia, Tapan, Borthakur, Gautam, Pemmaraju, Naveen, Sasaki, Koji, Estrov, Zeev, Cortes, Jorge, Ravandi, Farhad, Alvarado, Yesid, Komrokji, Rami, Sekeres, Mikkael A., Steensma, David P., DeZern, Amy, Roboz, Gail, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado no Blood (2017)